Tom Wolf, who leads West Coast initiatives for the Foundation for Drug Policy Solutions, has become a leader in the recovery-first movement. […]

Provisional data from the Centers for Disease Control and Prevention (CDC) indicate that overdose deaths declined from 81,313 in 2024 […]

Tom Wolf, who leads West Coast initiatives for the Foundation for Drug Policy Solutions, has become a leader in the recovery-first movement.

Provisional data from the Centers for Disease Control and Prevention (CDC) indicate that overdose deaths declined from 81,313 in 2024 […]

A recent study in the International Journal of Drug Policy, citing data from the 2023 International Cannabis Policy Study, found that 6% of […]

A recent survey from Faces & Voices of Recovery, a national leader in the drug policy field, found that Americans’ beliefs about addiction […]

The Trump administration’s recent attempts to loosen the nation’s laws regarding marijuana and psychedelics mark a significant departure from the positions favored […]

This data compounds a series of studies undermining claims that marijuana is medicine.

This post is reprinted with permission from Sue’s Substack, by Sue Rusche. Both complaints say that all four companies market and […]

The wider administration has taken steps to profoundly normalize the drug and open the door to significant further commercialization.
First it was Mehmet Oz, the guru of pseudoscience, who began giving an FDA-unapproved drug—CBD—to Medicare patients.
Despite the industry--and now the federal government--claiming that marijuana has therapeutic benefits, evidence continues to emerge showing that the drug reduces health.

A recent study in the International Journal of Drug Policy, citing data from the 2023 International Cannabis Policy Study, found that 6% of […]

A recent survey from Faces & Voices of Recovery, a national leader in the drug policy field, found that Americans’ beliefs about addiction […]

The Trump administration’s recent attempts to loosen the nation’s laws regarding marijuana and psychedelics mark a significant departure from the positions favored […]

This post is reprinted with permission from Sue’s Substack, by Sue Rusche. Both complaints say that all four companies market and […]

The wider administration has taken steps to profoundly normalize the drug and open the door to significant further commercialization. 

First it was Mehmet Oz, the guru of pseudoscience, who began giving an FDA-unapproved drug—CBD—to Medicare patients.

Despite the industry--and now the federal government--claiming that marijuana has therapeutic benefits, evidence continues to emerge showing that the drug reduces health.

Scroll to Top